Skip to main content
SpringerLink
Log in

Molecular link between cholesterol, cytokines and atherosclerosis

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Current investigation on the origin of atherosclerosis has initiated an intense debate over whether atherosclerosis results from hypercholesterolemia or an inappropriate immune response to vascular injury. Although the role of the immune system has been questioned, the overwhelming body of evidence clearly indicates that atherogenesis is initiated by the interplay between cholesterol and cellular secretion of cytokines (especially IL-6) and apolipoprotein ‘E’ within the arterial wall. Recent studies have revealed that cells possess two cholesterol-sensors: (a) Receptor-Ck which senses the extracellular cholesterol and initiates signalling pathway responsible for the regulation of genes involved in the cell cycle, cell death, cellular cholesterol homeostasis and cytokines including IL-6; (b) LxRα which senses intracellular oxysterols and controls genes involved in cell death, cellular cholesterol homeostasis and cytokine IL-8. These cholesterol sensors define the molecular mechanism responsible for cholesterol-depended regulation of cellular synthesis and secretion of cytokines (IL-6, IL-8) within arterial wall. On the basis of this mechanism, presence of cholesterol and its oxy-derivative in the modified LDL will result in transient activation/deactivation of Receptor-Ck-dependent genes which will give rise to repeated cycles of growth coupled with apoptosis leading to a situation where apoptotic-deficient cells in the arterial wall, would be selected resulting in their accumulation and formation of oligoclonal atherosclerotic plaque.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wick G, Schelt G, Amberger A, Kleindienst R, Xu Q: Is atherosclerosis an immunologically mediated disease? Immunol Today 16: 27–33, 1995

    Google Scholar 

  2. Fyte AI, Qiao JH, Lusis AJ: Immunodeficient mice develop typical atherosclerotic fatty streak when fed an atherogenic diet. J Clin Invest 94: 2516–2520, 1994

    Google Scholar 

  3. Laman JD, deSmet BJGL, Schoneveld A, Meurs MV: CD4o-CD40L interaction in atherosclerosis. Immunol Today 18: 272–277, 1997

    Google Scholar 

  4. Mehta U, Kaul D: Nature of aortic smooth muscle cellular activity induced by cholesterol incorporation through an LDL-receptor independent pathway: Role of trifluoperazine on such activity. Exp Mol Pathol 55: 13–24, 1991

    Google Scholar 

  5. Lusis AJ, Navab M: Lipoprotein oxidation and gene expression in arterial wall. New opportunities of pharmacological intervention in atherosclerosis. Biochem Pharmacol 46: 2119–2136, 1993

    Google Scholar 

  6. Palinski W, Rozenfeld ME, Vla-HerHuala S, Gurtner GC, Socker SS, Butler SW et al.: Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 86: 1372–1376, 1989

    Google Scholar 

  7. Keys A: Cornary heart disease - the global picture. Atherosclerosis 22: 149–192, 1975

    Google Scholar 

  8. Buchwald H: Cholesterol inhibition, cancer and chemotherapy. Lancet 339: 1154–1156, 1992

    Google Scholar 

  9. Vitols S, Norgen S, Juliusson G, Tabtidies L, Luthman H: Multilevel regulation of low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenyme A reductase gene expression in normal and leukemic cells. Blood 84: 2689–2698, 1994

    Google Scholar 

  10. Brown MS, Goldstein SL: A receptor mediated pathway for cholesterol homeostasis. Science 232: 37–47, 1986

    Google Scholar 

  11. Goldstein JL, Brown MS: Regulation of the mevalonate pathway. Nature 343: 425–430, 1990

    Google Scholar 

  12. Vaux DL, Strasser A: The molecular biology of apoptosis. Proc Natl Acad Sci USA 93: 2239–2244, 1996

    Google Scholar 

  13. Roma P, Catapano AL, Bertulli SM, Varesi L, Fumagelli R, Bernini F: Oxidized LDL increases free cholesterol and fail to stimulate cholesterol esterfication in murine macrophages. Biochem Biophys Res Commun 171: 123–131, 1990

    Google Scholar 

  14. Young SG, Parthasarathy S: Why are low-density lipoproteins atherogenic? West J Med 160: 153–164, 1994

    Google Scholar 

  15. Ferman BM, Ruan B, Chen J, Schroepter GJ Jr, Evans RM: The orphan nuclear receptor LxRα is positively and negatively regulated by distinct products of mevalonate metabolism. Proc Natl Acad Sci USA 94: 10588–10593, 1997

    Google Scholar 

  16. Ntambi JM: Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J Lipid Res 40: 1549–1558, 1999

    Google Scholar 

  17. Kaul D: Do human platelets posses LDL-receptor specific for apoprotein ‘B’ or cholesterol? Curr Sci 65: 883–886, 1993

    Google Scholar 

  18. Kaul D: Receptor Ck and leukemogenesis. Leuk Res 22: 389–394, 1998

    Google Scholar 

  19. Goel R, Kaul D, Varma S: Lymphocytes from CML patients lack 47 kDa factor having affinity for genomic sterol regulatory sequence. Leuk Res 20: 877–879, 1996

    Google Scholar 

  20. Goel R, Varma S, Kaul D: Sterol dependent LDL-receptor gene transcription from normal and CML patients gene transcription from normal and CML patients. Cancer Lett 107: 193–198, 1996

    Google Scholar 

  21. Goel R, Singh J, Kaul D: Receptor-Ck dependent signalling regulates LDL receptor transcription. Mol Cell Biochem 169: 79–83, 1997

    Google Scholar 

  22. Sujimoto Y, Croce CM: Analysis of the structure transcripts and protein products of Bcl-2, the gene involved in follicular lymphoma. Proc Natl Acad Sci USA 83: 5214–5218, 1986

    Google Scholar 

  23. Herber B, Truss M, Beato M, Muller R: Inducible regulating elements in the human cyclin ‘D’ promoter. Oncogene 9: 1295–1304, 1994

    Google Scholar 

  24. Shimano H, Horton JD, Shimomura L, Hammer RE, Brown MB, Godstein JL: Isoform Ic of sterol regulatory element binding protein in less active than isoform Ia in livers of transgenic mice in cultured cells. J Clin Invest 99: 846–854, 1997

    Google Scholar 

  25. Moolenaar WA, Kruijer W, Tilly BC, Verlann I, Bierman AJ, deLaat SW: Growth factor-like action of phosphatidic acid. Nature 323: 171–173, 1986

    Google Scholar 

  26. Kaur M, Kaul D, Sobti RC: Receptor-Ck dependent regulation of genes involved in the cell cycle. Mol Cell Biochem 181: 137–142, 1998

    Google Scholar 

  27. Kaul D, Kaur M: Receptor-Ck regulates the expression of cyclin-dependent kinase inhibitors. Mol Cell Biochem 200: 183–186, 1999

    Google Scholar 

  28. Kaul D, Kaur M: Receptor-Ck central cholesterogenesis and DNA replication in HepG2 cells. Curr Sci 77: 592–594, 1999

    Google Scholar 

  29. Brown MS, Goldstein JL: The SREBP Pathway-regulation of cholesterol metabolism by proteolysis of a membrane bond transcription factor. Cell 89: 331–340, 1997

    Google Scholar 

  30. Stark AC, Weinberger O, Weinberger J: Common double and single stranded DNA binding factor for a sterol regulating element. Proc Natl Acad Sci USA 89: 2180–2184, 1992

    Google Scholar 

  31. Lopez D, Ness GC: Inhibitors of 3-hydrocy-3-methylglutaryl coenzyme. A reductase unmask transcriptional regulation of hepatic low density lipoprotein gene expression by dietary cholesterol. Arch Biochem Biophys 344: 215–219, 1999

    Google Scholar 

  32. Linette GP, Li Y, Roth K, Korsmeyer SJ: Cross-talk between cell death and cell cycle progression: Bcl-2 regulates NFAT-mediated activation. Proc Natl Acad Sci USA 93: 9545–9552, 1996

    Google Scholar 

  33. Fielding CJ, Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res 36: 211–228, 1995

    Google Scholar 

  34. Hill SA, McQueen MJ: Reverse cholesterol transport - a review of the process and its clinical implications. Clin Biochem 30: 517–525, 1997

    Google Scholar 

  35. Barroaus A, Jaspard B, Barbaras R, Chap H, Perret B, Collect X: Prebeta HDL: Structure and metabolism. Biochem Biophys Acta 1300: 73–85, 1996

    Google Scholar 

  36. Yamashita S, Maruyama T, Ken-ichi H, Sakai N, Nakajima N, Matsuzana Y: Molecular mechanisms, lipoprotein abnormalities and atherogenecity of hyperalphalipoproteinemia. Atherosclerosis 152: 271–285, 2000

    Google Scholar 

  37. Rubin EM, Krauss RM, Spangler EA, Uerstuyft JG, Cliff SM: Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature 353: 265–267, 1991

    Google Scholar 

  38. Piero C, Carmen G, Jose MO, Jose CR, Javier L: Induction of apolipoprotein ‘E’ gene expression in human and experimental atherosclerotic lesions. Biochem Biophys Res Commun 168: 733–740, 1990

    Google Scholar 

  39. Mahley RW, Innerarity TL: Lipoprotein receptors and cholesterol homeostasis. Biochem Biophys Acta 737: 197–222, 1983

    Google Scholar 

  40. Laskowitz DT, Lee DM, Schemechel D, Staats HF: Altered immune responses in apolipoprotein ‘E'-deficient mice. J Lipid Res 41: 613–620, 2000

    Google Scholar 

  41. Cader AA, Steinberg FM, Mazzone T, Chait A: Mechanisms of enhanced macrophage apo-'E’ secreted by oxidized LDL. J Lipid Res 38: 981–991, 1997

    Google Scholar 

  42. Schroepfer GJ Jr: Oxysterols: Modulators of cholesterol metabolism and other processes. Physiol Rev 80: 361–554, 2000

    Google Scholar 

  43. Mehta U, Kaul D: Nature of aortic smooth muscle cellular activity induced by cholesterol-incorporation through LDL-receptor independent pathway: Preventive role of Trifiperazine on such activity. Exp Mol Pathol 55: 13–24, 1991

    Google Scholar 

  44. Liu Y, Hulten LM, Wiklund O: Macrophages isolated from human atherosclerotic plaques produce IL-8 and oxysterols may have a regulatory function for IL-8 production. Arterioscler Thromb Vasc Biol 17: 317–323, 1997

    Google Scholar 

  45. Rus HG, Vlaicu R, Niculescu F: Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 127: 263–271, 1996

    Google Scholar 

  46. Seino Y, Ikeda U, Ikeda M, Yamamoto K, Misawa Y, Hasegawa T, Kano S, Shimado K: Interleukin-6 gene transcripts are expressed in human atherosclerotic lesions. Cytokines 6: 87–91, 1994

    Google Scholar 

  47. Ikeda U, Ikeda M, Seino Y, Takashashi M, Kano S, Shinada K: Interleukin-6 gene transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits. Atherosclerosis 92: 213–218, 1992

    Google Scholar 

  48. Yudkin JS, Kumari M, Humphries SE, Mohamad-Ali V: Inflammation. Obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 148: 209–214, 2000

    Google Scholar 

  49. Skretting G, Gjernes E, Prydz H: Regulation of lecithin: Cholesterol acyltransferase by TGF-beta and interleukin-6. Biochem Biophys Acta 1255: 267–272, 1995

    Google Scholar 

  50. Zuckerman SH, Evans GF, O'Neal A: Cytokine regulation of macrophage apo-'E’ secretion: Opposing effects of GM-CSF and TGF-beta. Atherosclerosis 96: 203–214, 1992

    Google Scholar 

  51. Mech F, Schonbeck U, Sukhova GK, Atkinson E, Libby P: Reduction of atherosclerosis in mice by inhibiting CD4o signalling. Nature 394: 200–203, 1998

    Google Scholar 

  52. Dechanet J, Grosset C, Taupin JL, Merville P, Bauchereau J, Ripoche J, Moreau JF: CD4o ligand stimulates proinflammatory cytokine production by human endothelial cells. J Immunol 159: 5640–5647, 1997

    Google Scholar 

  53. Urashima M, Chauhan D, Hatziyanni M, Ogata A, Hollenbaugh D, Aruffo A, Anderson KC: CD4o ligand triggers interleukin-6 mediated B-cell differentiation. Leuk Res 20: 507–515, 1996

    Google Scholar 

  54. Clark EA, Shu G: Association between IL-6 and CD4o signalling. IL-6 induced phosphorylation of CD4o receptors. J Immunol 145: 1400–1406, 1990

    Google Scholar 

  55. Sukovich DA, Kauser K, Shirley FD, Delvecchio V, Halks-Miller M, Rubanyi GM: Expression of interleukin-6 in atherosclerotic lesions of male apo ‘E'-knockout mice: Inhibition by 17 β-estradiol. Arterioscler Thromb Vasc Biol 18: 1498–1505, 1998

    Google Scholar 

  56. Moolenaar WH, Kruijer W, Tilly BC, Verlaan I, Biermanp AJ, de Latt SW: Growth factor-like action of phosphatidic acid. Nature 323: 171–173, 1986

    Google Scholar 

  57. Freeman EJ: The Ang II-induced growth of vascular smooth muscle cells involves a phospholipase ‘D'-mediated signalling mechanism. Arch Biochem Biophys 374: 363–370, 2000

    Google Scholar 

  58. Luo Y, Tall AR: Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J Clin Invest 105: 513–520, 2000

    Google Scholar 

  59. Leszczynski D, Zhao Y, Luokkamaki M, Foegh ML: Apoptosis of smooth muscle cells: Protein kinase ‘C’ and oncoprotein Bcl-2 are involved in regulation of apoptosis in nontransformed Rat vascular smooth muscle cells. Am J Pathol 145: 1265–1270, 1999

    Google Scholar 

  60. Jiang C, Ting AT, Seed B: PPAR-g agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82–88, 1998

    Google Scholar 

  61. Berg K: Twin research in coronary heart disease. Prog Clin Biol Res 69C: 117–130, 1981

    Google Scholar 

  62. Brada M: Bcl-2 gene: Current relevance to clinical oncology. Eur J Cancer 28: 270–272, 1992

    Google Scholar 

  63. Bissonette RP, Echeverri F, Maliboubi A, Green DR: Apoptotic cell death induced by c-myc is inhibited by Bcl-2. Nature 359: 552–554, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Experimental Medicine and Biotechnology, Post Graduate, Institute Medical Education and Research, Chandigarh, 160 012, India

    D. Kaul

Authors
  1. D. Kaul
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaul, D. Molecular link between cholesterol, cytokines and atherosclerosis. Mol Cell Biochem 219, 65–71 (2001). https://doi.org/10.1023/A:1011006707414

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011006707414

Search

Navigation